PGD2 receptor antagonists for the treatment of inflammatory diseases
AssigneeMillennium Pharmaceuticals, Inc.
InventorsShomir Ghosh, Amy M. Elder, Kenneth G. Carson, Kevin Sprott, Sean Harrison
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compounds represented by Structural Formula (I): 1 (I), wherein the variables are defined herein. Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 (“CRTH2”) for the treatment of inflammatory disorders.
Claims24
A method of inhibiting CRTH2 in a subject in need of CRTH2 inhibition, comprising administering to the subject an effective amount of a compound represented by the following structural formula:
- 593
- or a pharmaceutically acceptable salt thereof, wherein:
- Ring A is an optionally substituted monocyclic aromatic ring;
- R is —X1—R1;
- Rx is —X2—R4, and R3 is an optionally substituted, cycloaliphatic group, aromatic group or non-aromatic heterocyclic group;
- or —NRxR3, taken together, is an optionally substituted non-aromatic nitrogen containing heterocyclic group;
- X is —C(O)— or —C(R2)2—;
- X1 and X2 are each independently a bond, S(O), S(O)2, C(O) or C(O)NH;
- R1 is H or an optionally substituted, cycloaliphatic group, aromatic group or non-aromatic heterocyclic group;
- provided that when X1 is a bond, SO or SO2, then R1 is not H;
- each R2 is independently H, —X4—R8 or an optionally substituted, aliphatic group, cycloaliphatic group, aromatic group or non-aromatic heterocyclic group;
- R4 is H, —X6—R10 or an optionally substituted, aliphatic group, cycloaliphatic group, aromatic group or non-aromatic heterocyclic group;
- provided that when X2 is a bond, SO or SO2, then R4 is not H;
- X4 and X6 are each independently a straight or branched hydrocarbyl group optionally substituted with one or more groups selected from the group consisting of halo, —OH, ═O, C1-C3 alkoxy, nitro and cyano;
- R5 and R6 are each independently H or C1-C3 alkyl;
- and
- R8 and R10 are each independently H, —C(O)OR′ or an optionally substituted, cycloaliphatic group, aromatic group or non-aromatic heterocyclic group;
- where,
- the optional substituents on the aliphatic group, the cycloaliphatic group or the non-aromatic heterocyclic group are one to three groups each independently selected from the group consisting of halo, R11, ═O, ═S, ═NNHR*, ═NN(R*)2, ═NNHC(O)R*, ═NNHCO2(alkyl), ═NNHSO2 (alkyl) and ═NR*;
- the optional substituents on unsaturated carbon atoms of the aromatic group is R11;
- the optional substituents on a nitrogen atom of the aromatic group or the nitrogen atom of the non-aromatic nitrogen containing heterocyclic group are one to three groups each independently selected from the group consisting of R+, —N(R+)2, —C(O)R+, —CO2 R+, —C(O)C(O)R+, —C(O)CH2C(O)R+, —SO2 R+, —SO2N(R+)2, —C(═S)N(R+)2, —C(═NH)—N(R+)2 and —NR+SO2R+;
- R11 is one to four substituents each independently selected from the group consisting of halo, Ro, —OH, —ORo, —SH, —SRo, 1,2-methylenedioxy, 1,2-ethylenedioxy, protected —OH, phenyl, [R12]-phenyl, —O(phenyl), —O([R12]-phenyl), —CH2(phenyl), —CH2([R12]-phenyl), —CH2CH2(phenyl), —CH2CH2([R12]-phenyl), —NO2, —CN, —N(R′)2, —NR′CO2Ro, —NR′C(O)Ro, —NR′NR′C(O)Ro, —N(R′)C(O)N(R′)2, —NR′NR′C(O)N(R′)2, —NR′NR′CO2Ro, —C(O)C(O)Ro, —C(O)CH2C(O)R′, —CO2R′, —C(O)o, —C(O)N(R′)2, —OC(O)N(R′)2, —S(O)2Ro, —SO2N(R′)2, —S(O)R′, —NR′SO2N(R′)2, —NR′SO2Ro, —C(═S)N(R′)2, —(CH2)yN(R′)2, —C(═NH)—N(R′)2, —(CH2)yC(O)N(R′)2, —(CH2)yNHC(O)R′ or —(CH2)yNHC(O)CH(V-R′)(R′);
- R′ is H, Ro, —CO2Ro, —SO2Ro or —C(O)Ro;
- y is 0-6;
- V is C1-C6 alkylene;
- each R* is independently H, an aliphatic group or an aliphatic group substituted with R12;
- R+ is H, phenyl, [R12]-phenyl, —O(phenyl), —O([R12]-phenyl), —CH2(phenyl), —CH2([R12]-phenyl), a heteroaryl group, a non-aromatic heterocyclic group, an aliphatic group or an aliphatic group substituted with R12;
- Ro is an aliphatic group, a cycloaliphatic group, an aromatic group, an aralkyl group or a non-aromatic heterocyclic group, each group being optionally substituted with R12;
- R12 is one to four substituents each independently selected from the group consisting of halo, C1-C6 alkyl, (halo)rC1-C6 alkyl, C3-C8 cycloalkyl, (halo)rC3-C8 cycloalkyl, —CN, —CF3, —CHF2, —CH2F, —OCF3, —OCHF2, —OCH2F, —OR′, —OR13C(O)R′, —C(O)OR′, —C(O)N(R16)2, —N(R16)2)—NO2, —NR16C(O)R′, —NR16C(O)OR′, —NR16C(O)N(R16)2, —NR16SO2R17, —S(O)qR17, —R13NR16C(O)R′, —R13C(O)R′, —R13NR16C(O)OR′, tetrazolyl, imidazolyl or oxadiazolyl;
- R13 is C1-C6 alkyl or C3-C8 cycloalkyl;
- each R16 is independently R′ or benzyl;
- R17 is R13 or —CF3;
- q is 0-2;
- and
- r is 1-3.
A compound represented by the following structural formula:
- 595
- or a pharmaceutically acceptable salt thereof, wherein:
- Ring A is an optionally substituted monocyclic aromatic ring;
- R is —X1—R1;
- Rx is —X2—R4, and R3 is an optionally substituted aromatic group;
- or
- —NRxR3, taken together, is an optionally substituted non-aromatic nitrogen containing heterocyclic group;
- X is —C(O)— or —C(R2)2—;
- X1 and X2 are each independently a bond, S(O), S(O)2, C(O) or C(O)NH;
- R1 is H or an optionally substituted, cycloaliphatic group, aromatic group or non-aromatic heterocyclic group;
- provided that when X1 is a bond, SO or SO2, then R1 is not H;
- each R2 is independently H, —X4—R8 or an optionally substituted, aliphatic group, cycloaliphatic group, aromatic group or non-aromatic heterocyclic group;
- R4 is H, —X6—R10 or an optionally substituted, aliphatic group, cycloaliphatic group, aromatic group or non-aromatic heterocyclic group;
- provided that when X2 is a bond, SO or SO2, then R4 is not H;
- X4 and X6 are each independently a straight or branched hydrocarbyl group optionally substituted with one or more groups selected from the group consisting of halo, —OH, ═O, C1-C3 alkoxy, nitro and cyano;
- R5 and R6 are each independently H or C1-C3 alkyl;
- and
- R8 and R10 are each independently H, —C(O)OR′ or an optionally substituted, cycloaliphatic group, aromatic group or non-aromatic heterocyclic group;
- where,
- the optional substituents on the aliphatic group, the cycloaliphatic group or the non-aromatic heterocyclic group are one to three groups each independently selected from the group consisting of halo, R11, ═O, ═S, ═NNHR*, ═NN(R*)2, ═NNHC(O)R*, ═NNHCO2(alkyl), ═NNHSO2 (alkyl) and ═NR*;
- the optional substituents on unsaturated carbon atoms of the aromatic group is R11;
- the optional substituents on a nitrogen atom of the aromatic group or the nitrogen atom of the non-aromatic nitrogen containing heterocyclic group are one to three groups each independently selected from the group consisting of R+, N(R+)2, —C(O)R+, —CO2 R+, —C(O)C(O)R+, —C(O)CH2C(O)R+, —SO2 R+, —SO2N(R+)2, —C(═S)N(R+)2, —C(═NH)—N(R+)2 and —NR+SO2R+;
- R11 is one to four substituents each independently selected from the group consisting of halo, Ro, —OH, —ORo, —SH, —SRo, 1,2-methylenedioxy, 1,2-ethylenedioxy, protected —OH, phenyl, [R12]-phenyl, —O(phenyl), —O([R12]-phenyl), —CH2(phenyl), —CH2([R12]-phenyl), —CH2CH2(phenyl), —CH2CH2([R12]-phenyl), —NO2, —CN, —N(R′)2, —NR′CO2Ro, —NR′C(O)Ro, —NR′NR′C(O)Ro, —N(R′)C(O)N(R′)2, —NR′NR′C(O)N(R′)2, —NR′NR′CO2Ro, —C(O)C(O)Ro, —C(O)CH2C(O)R′, —CO2R′, —C(O)Ro, —C(O)N(Ro)2, —OC(O)N(R′)2, —S(O)2Ro, —SO2N(R′)2, —S(O)R′, —NR′SO2N(R′)2, —NR′SO2Ro, —C(═S)N(R′)2, —(CH2)yN(R′)2, —C(═NH)—N(R′)2, —(CH2)yC(O)N(R′)2, —(CH2)yNHC(O)R′ or —(CH2)yNHC(O)CH(V-R′)(R′);
- R′ is H, Ro, —CO2Ro, —SO2Ro or —C(O)Ro;
- y is 0-6;
- V is C1-C6 alkylene;
- each R* is independently H, an aliphatic group or an aliphatic group substituted with R12;
- R+is H, phenyl, [R12]-phenyl, —O(phenyl), —O([R12]-phenyl), —CH2(phenyl), —CH2([R12]-phenyl), a heteroaryl group, a non-aromatic
- heterocyclic group, an aliphatic group or an aliphatic group substituted with R12;
- Ro is an aliphatic group, a cycloaliphatic group, an aromatic group, an aralkyl group or a non-aromatic heterocyclic group, each group being optionally substituted with R12;
- R12 is one to four substituents each independently selected from the group consisting of halo, C1-C6 alkyl, (halo)rC1-C6 alkyl, C3-C8 cycloalkyl, (halo)rC3-C8 cycloalkyl, —CN, —CF3, —CHF2, —CH2F, —OCF3, —OCHF2, —OCH2F, —OR′, —OR13C(O)R′, —C(O)OR′, —C(O)N(R16)2, —N(R16)2, —NO2, —NR16C(O)R′, —NR16C(O)OR′, —NR16C(O)N(R16)2, —NR16SO2R17, —S(O)qR17, —R13NR16C(O)R′, —R13C(O)R′, —R13NR16C(O)OR′, tetrazolyl, imidazolyl or oxadiazolyl;
- R13 is C1-C6 alkyl or C3-C8 cycloalkyl;
- each R16 is independently R1 or benzyl;
- R17 is R13 or —CF3;
- q is 0-2;
- and
- r is 1-3;
- provided that the compound is not 2-methyl-N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(2-methyl-1-oxobutyl)-4-quinolinyl]-butamide;
- N-(1-Acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-heptamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(1-oxo-3-phenylpropyl)-4-quinolinyl]-benzenepropanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(3-nitrobenzoyl)-4-quinolinyl]-hexanamide;
- N-[1,1′-biphenyl]-3-yl-N-[1,2,3,4-tetrahydro-1-(4-methoxybenzoyl)-2-methyl-4-quinolinyl]-acetamide;
- N-(1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-(4-nitrophenyl)-heptanamide;
- N-(1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-(4-methoxyphenyl)-2-methyl-propanamide;
- N-[1-(4-fluorobenzoyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-butanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(3-methoxybenzoyl)-2-methyl-4-quinolinyl]-pentanamide;
- 2-ethyl-N-[1-(2-ethyl-1-oxobutyl)-1,2,3,4-tetrahydro-2,8-dimethyl-4-quinolinyl]-N-(2-methylphenyl)-butanamide;
- N-[1-[(4-fluorophenyl)acetyl]-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-propanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(4-nitrobenzoyl)-4-quinolinyl]-octanamide;
- N-cyclohexyl-4-[(cyclohexylamino)carbonyl]phenylamino]-3,4-dihydro-2-methyl-1 (2H)-quinolinecarboxamide;
- N-[1-(4-ethylbenzoyl)-1,2,3,4-tetrahydro-2,8-dimethyl-4-quinolinyl]-N-(2-methylphenyl)-3-(4-nitrophenyl)-2-propenamide;
- 3-(4-methoxyphenyl)-N-phenyl-N-[1,2,3,4-tetrahydro-1-[3-(4-methoxyphenyl)-1-oxo-2-propenyl]-2-methyl-4-quinolinyl]-2-propenamide;
- 4-[(ethoxyoxoacetyl)phenylamino]-3,4-dihydro-2-methyl-∀-oxo-ethyl ester-1(2H)-quinolineacetic acid;
- N-[1-(3-cyclohexyl-1-oxopropyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-cyclohexanepropanamide;
- 4-(acetylphenylamino)-3,4-dihydro-2-methyl-gamma-oxo-1 (2H)-quinolinepentanoic acid;
- N-(1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-2,2-dimethyl-N-phenyl-propanamide;
- N-(1-benzoyl-6-bromo-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-pentanamide;
- N-[1-(2-furanylcarbonyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-acetamide;
- 2-methyl-N-phenyl-N-[1,2,3,4-tetrahydro-1-(3-methoxybenzoyl)-2-methyl-4-quinolinyl]-propanamide;
- N-[1-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)acetyl]-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-acetamide;
- 2,2,2-trifluoro-N-phenyl-N-[1,2,3,4-tetrahydro-1-(3-methoxybenzoyl)-2-methyl-4-quinolinyl]-acetamide;
- 2-ethyl-N-[1-(2-ethyl-1-oxobutyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-butanamide;
- N-(1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-(3-methoxyphenyl)-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(1-oxohexyl)-4-quinolinyl]-acetamide;
- N-(1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-2-thiophenecarboxamide;
- N-[1-(2-fluorobenzoyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-hexanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(4-methoxybenzoyl)-2-methyl-4-quinolinyl]-hexanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(4-methoxybenzoyl)-2-methyl-4-quinolinyl]-hexanamide;
- N-[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-cyclopropanecarboxamide;
- N-(1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-(4-methylphenyl)-acetamide;
- 2-methyl-N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(2-methyl-1-oxopropyl)-4-quinolinyl]-propanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(4-methoxybenzoyl)-2-methyl-4-quinolinyl]-2-thiophenecarboxamide;
- 1-(3,5-dinitrobenzoyl)-N-formyl-1,2,3,4-tetrahydro-2-methyl-N-phenyl-4-quinolinamine;
- N-[1-(4-chloro-3-nitrobenzoyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(3-nitrobenzoyl)-4-quinolinyl]-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(3-methoxybenzoyl)-2-methyl-4-quinolinyl]-hexanamide;
- N-[1-(2-furanylcarbonyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-2-furancarboxamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(1-oxopropyl)-4-quinolinyl]-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-[3-(4-methoxyphenyl)-1-oxo-2-propenyl]-2-methyl-4-quinolinyl]-acetamide;
- 3-(2-furanyl)-N-[1-[3-(2-furanyl)-1-oxo-2-propenyl]-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-2-propenamide;
- N-[1-[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-oxo-3-phenylpropyl]-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-octanamide;
- N-[1-(3-chlorobenzoyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-acetamide;
- Relative stereochemistry N-phenyl-N-[(2R,4S)-1,2,3,4-tetrahydro-2-methyl-1-(1-oxopropyl)-4-quinolinyl]-acetamide;
- Relative stereochemistry N-[(2R,4S)-1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-2-methyl-N-phenyl-propanamide;
- Relative stereochemistry N-[(2R,4S)-1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-hexanamide;
- Relative stereochemistry N-[(2R,4S)-1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-propanamide;
- Relative stereochemistry N-[(2R,4S)-1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-heptanamide;
- Relative stereochemistry N-[(2R,4S)-1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-2,2-dimethyl-N-phenyl-propanamide;
- N-[1-(3-fluorobenzoyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-acetamide;
- N-[1-[4-(1,1-dimethylethyl)benzoyl]-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-acetamide;
- N-(1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-2-methyl-N-phenyl-propanamide;
- 2,2,2-trifluoro-N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(trifluoroacetyl)-4-quinolinyl]-acetamide;
- Relative stereochemistry N-[(2R,4S)-1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-2,2-dimethyl-N-phenyl-propanamide;
- Relative stereochemistry N-[(2R,4S)-1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-butanamide;
- Relative stereochemistry N-[(2R,4S)-1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-acetamide;
- Relative stereochemistry N-phenyl-N-[(2R,4S)-1,2,3,4-tetrahydro-2-methyl-1-(1-oxoheptyl)-4-quinolinyl]-acetamide;
- Relative stereochemistry N-phenyl-N-[(2R,4S)-1,2,3,4-tetrahydro-2-methyl-1-(1-oxohexyl)-4-quinolinyl]-acetamide;
- Relative stereochemistry N-[(2R,4S)-1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-pentanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(1-oxo-3-phenyl-2-propenyl)-4-quinolinyl]-acetamide;
- Relative stereochemistry N-[(2R,4S)-1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-heptanamide;
- Relative stereochemistry N-[(2R,4S)-1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-acetamide;
- Relative stereochemistry N-[(2R,4S)-1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-pentanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(tricyclo[3.3.1.13,7]dec-1-ylcarbonyl)-4-quinolinyl]-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(1-oxopropyl)-4-quinolinyl]-propanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(2-thienylcarbonyl)-4-quinolinyl]-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(4-methoxybenzoyl)-2-methyl-4-quinolinyl]-2-furancarboxamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(4-methoxybenzoyl)-2-methyl-4-quinolinyl]-acetamide;
- N-[1-(3,5-dinitrobenzoyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl]-N-phenyl-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(4-nitrobenzoyl)-4-quinolinyl]-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(2-iodobenzoyl)-2-methyl-4-quinolinyl]-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(2-methyl-1-oxopropyl)-4-quinolinyl]-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-[(4-methylphenyl)sulfonyl]-4-quinolinyl]-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-[(4-nitrophenyl)methyl]4-quinolinyl]-acetamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(3-methoxybenzoyl)-2-methyl-4-quinolinyl]-acetamide;
- N-(1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-butanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-2-methyl-1-(1-oxobutyl)-4-quinolinyl]-acetamide;
- N-(1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-hexanamide;
- N-(1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-pentanamide;
- N-(1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-propanamide;
- 1-benzoyl-1,2,3,4-tetrahydro-4-(N-phenylacetamido)quinaldine;
- N-(1-acetyl-6-bromo-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-acetamide;
- N-(1-acetyl-1,2,3,4-tetrahydro-2-methyl-6-nitro-4-quinolyl)-acetanilide;
- N-(1-acetyl-6-chloro-1,2,3,4-tetrahydro-2-methyl-4-quinolyl)-acetanilide;
- N-(1-acetyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-acetamide;
- N-(1-benzoyl-6-bromo-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-acetamide;
- N-(1-benzoyl-6-chloro-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-acetamide;
- N-(1-benzoyl-1,2,3,4-tetrahydro-2-methyl-4-quinolinyl)-N-phenyl-butanamide;
- N-phenyl-N-[1,2,3,4-tetrahydro-1-(3-fluorobenzoyl)-2-methyl-4-quinolinyl]-hexanamide;
- N-[1-(3-chloro-benzoyl)-2-methyl-1,2,3,4-tetrahydro-quinolin-4-yl]-N-phenyl-acetamide;
- N-[1-(4-fluoro-benzoyl)-2-methyl-6-nitro-1,2,3,4-tetrahydro-quinolin-4-yl]-N-phenyl-acetamide;
- pentanoic acid (1-benzoyl-6-bromo-2-methyl-1,2,3,4-tetrahydro-quinolin-4-yl)-phenyl-amide;
- N-(1-benzoyl-6-chloro-2-methyl-1,2,3,4-tetrahydro-quinolin-4-yl)-N-phenyl-acetamide;
- N-[6-chloro-1-(4-fluoro-benzoyl)-2-methyl-1,2,3,4-tetrahydro-quinolin-4-yl]-N-phenyl-acetamide;
- N-[6-bromo-1-(4-fluoro-benzoyl)-2-methyl-1,2,3,4-tetrahydro-quinolin-4-yl]-N-phenyl-acetamide;
- N-(1-benzoyl-6-nitro-2-methyl-1,2,3,4-tetrahydro-quinolin-4-yl)-N-phenyl-acetamide;
- N-(1-benzoyl-2-methyl-1,2,3,4-tetrahydro-quinolin-4-yl)-N-phenyl-butyramide;
- N-[1-(3-methoxy-benzoyl)-2-methyl-1,2,3,4-tetrahydro-quinolin-4-yl]-2,2-dimethyl-N-phenyl-propionamide.
Dependencies are inferred from the claim text.